Sign In
Get Clay Free →

Suggestions

    Alex Sim

    CEO of AMS Biotechnology, experienced in biotech and life sciences industry

    Alex Sim is a multi-lingual entrepreneur with a strong background in transforming biomedical innovations into commercial success. He has a history of actively contributing to the development of techniques and tools to accelerate drug discovery and life science research. His expertise lies in business strategy and planning, sales, marketing, acquisitions, and forming successful joint ventures.

    Alex Sim holds a Postgraduate Diploma in Marketing and a Bachelor of Science in Biochemistry and Microbiology, both from the University of Strathclyde. Additionally, he completed a program at Goldman Sachs/UCL 10KSB, further enhancing his skills and knowledge.

    Throughout his career, Alex has held various key positions including CEO at AMS Biotechnology, Acting CEO at ScreenIn3D, President at AMSBIO LLC, Sales and Marketing Manager at Amersham International, Global Senior Product Manager at Amersham, and Vice President at University of Strathclyde Students' Association.

    His expertise and experience in business strategy, marketing, sales, acquisitions, and joint ventures have been instrumental in his success in taking new companies and products to market. Alex's contributions to the biomedical industry have been profound, making him a respected figure in the field.

    Highlights

    Strathclyde Spinout ScreenIn3D Secures Investment To ...
    Aug 22 · obn.org.uk
    ScreenIn3D announce ​​​​​​​lab-on-chip technology for ... - OBN
    Lab-on-Chip Technology for Screening Live Tumor
    Lab-on-Chip Technology for Screening Live Tumor
    Aug 18 · strath.ac.uk
    ScreenIn3D secures £225k seed investment to commercialise ...
    ScreenIn3D secures £225k seed investment to commercialise ...

    Related Questions

    What is Alex Sim's background in biotechnology?
    How did Alex Sim transition from AMS Biotechnology to ScreenIn3D?
    What are the key achievements of Alex Sim in his career?
    How does ScreenIn3D's technology work in drug development?
    What role did Alex Sim play in securing the £225k seed investment for ScreenIn3D?
    Alex Sim
    Alex Sim, photo 1
    Alex Sim, photo 2
    Get intro to Alex
    Add to my network

    Experience

    CEO at AMS Biotechnology since June 1988
    President at AMSBIO LLC since August 2011; Executive Chairman at ScreenIn3D since November 2018, Sales and Marketing Manager at Amersham International (1985 - 1987); Global Senior Product Manager at Amersham (1982 - 1985); Vice President at University of Strathclyde Students' Association (1978 - 1979)

    Education

    PG Dip in Marketing, BSc in Biochemistry and Microbiology from University of Strathclyde; Participant at Goldman Sachs/UCL 10KSB

    Location

    Cambridge, Massachusetts, United States